Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

NMDA receptors are ligand-gated ion channels that are found throughout the brain and are required for both brain development and many higher order functions. A variety of human patients with diverse clinical phenotypes have been identified that carry autoantibodies directed against NMDA receptor subunits. Here we focus on two general classes of autoantibodies, anti-GluN1 antibodies associated with anti-NMDA receptor encephalitis and anti-GluN2 antibodies associated with systemic lupus erythematosus (SLE). These two general classes of anti-NMDA receptor autoantibodies display a wide range of pathophysiological mechanisms from altering synaptic composition to gating of NMDARs. While we have made progress in understanding how these autoantibodies work at the molecular and cellular level, many unanswered questions remain including their long-term actions on brain function, the significance of clonal variations, and their effects on different NMDA receptor-expressing cell types in local circuits. This information will be needed to define fully the transition from anti-NMDA receptor autoantibodies to a clinical phenotype. Copyright © 2021 Elsevier Ltd. All rights reserved.

Citation

Lonnie P Wollmuth, Kelvin Chan, Laurent Groc. The diverse and complex modes of action of anti-NMDA receptor autoantibodies. Neuropharmacology. 2021 Aug 15;194:108624

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 34081993

View Full Text